SH3GL1 and diffuse large B-cell lymphoma: In DLBCL patients, 81 patients were divided into SH3GL1 low expression (26.2% with (−) and 38.1% with (+) expression), and 45 patients were grouped into high expression (22.2% with (++) expression, 9.5% with (+++) expression and 4.0% with (++++) expression) by IHC.